Join now to get the Newsheater.com pre-market morning brief 100% free. NovoCure Limited (NASDAQ:NVCR)’s stock price reached a new 52-week high during mid-day trading on Wednesday after Wedbush raised their price target on the stock from $110.00 to $159.00. NovoCure Limited (NASDAQ:NVCR) price closed higher on Monday, Dec 21, jumping 5.79% above its previous close. NovoCure Limited (NASDAQ:NVCR) went up by 7.30% from its latest closing price compared to the recent 1-year high of $131.14. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey. 171,21. Earnings per Share growth for this year is reported at 109.2, while the analysts estimated the EPS growth for next year at 1% and Earnings growth for next 5 years stands at 5.18% as estimated by the analysts. The stock added 35.29% on its value in the past month. Two Stocks To Ponder On: NovoCure Limited (NASDAQ:NVCR), … Performance wise the shares of Maxar Technologies Ltd. (NYSE:MAXR) rose up 0.86% for the week, it also rise 20.27% for the monthly performance, while for the quarter it went down 36.8%. NovoCure Limited (NASDAQ:NVCR) price closed higher on Monday, Dec 21, jumping 5.79% above its previous close. An analysis of the NovoCure Limited (NASDAQ:NVCR) stock in terms of its daily trading volume indicates that the 3-month average is 1.21 Million. The shares were sold at an average price of $157.39, for a total value of $32,722,954.90. NovoCure Ltd. develops treatment for tumors. The company has a market capitalization of $16.65 Billion. (NASDAQ: NVCR) NovoCure Ltd currently has 101,091,110 outstanding shares. The EPS estimate for next year as estimated by analysts is at 1 while EPS for next quarter is estimated at -0.13. NovoCure Limited (NASDAQ:NVCR)’s beta value is holding at 1.25, while the average true range (ATR) indicator is presently reading 8.59. The company’s 5Y monthly beta was ticking 1.25 while its P/E ratio in the trailing 12-month period read 2420.86. In the face of being in the red today for losing -0.63%, in the last five days NVCR remained trading in the green while hitting it’s week-highest on Monday, Dec 28 when the stock touched $179.62 price level, adding 3.66% to its value on the day. Nasdaq Futures 13,355.25 +61.00 (+0.46%) NovoCure Limited (NVCR) NasdaqGS - NasdaqGS Real Time Price. Click here now. A number of … NovoCure Ltd (NVCR) NovoCure Ltd. error_outline Atualizado às 12h23. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for NovoCure Limited (NASDAQ:NVCR) stands at 3.9, 7.4 and 0.2 respectively. Jun-02-20 07:30AM : We do not sell or share your information with anyone. The firm's revenue for the quarter was up 40.6% on a ye… NovoCure Limited (NASDAQ:NVCR) has been given an average recommendation of “Hold” by the eleven research firms that are covering the stock, MarketBeat reports. Elsewhere in the market, the S&P 500 Index has fell -0.39% in today’s early trading, with the Dow Jones Industrial also seeing a positive session so far with +0.12%. 1 month ago | Simply Wall St. Can NovoCure (NASDAQ:NVCR) Continue To Grow Its Returns On Capital? Company profile page for Novocure Ltd including stock price, company news, press releases, executives, board members, and contact information Price to Earnings (PE) ratio. Following the transaction, the chief executive officer now directly owns 301,587 shares in the … Simply Wall St. Jun-08-20 01:07AM : Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR) Insider Monkey. Investors will no doubt be excited should the share price rise to $117, which is the median consensus price, and at which level NVCR would be -30.96% from current price. December 8th, 2020 : 01:05: Chart of the Day. NovoCure Limited (NASDAQ:NVCR) went down by -6.37% from its latest closing price compared to the recent 1-year high of $182.74. The trailing twelve month Revenue of NovoCure Limited (NASDAQ:NVCR) is reported at 449.6 Million with income of 7.9 Million. With NovoCure Ltd stock trading at $171.97 per share, the total value of NovoCure Ltd stock (market capitalization) is $17.38B. Valuation. Per this projection, the revenue is forecast to grow +37.6% above that which the company brought in 2019. The EPS estimate for next year as estimated by analysts is at 0.42 while EPS for next quarter is estimated at 0.08. Now to discuss some of the Earning per Share estimates and growth estimates, shares of NovoCure Limited (NASDAQ:NVCR) produced diluted EPS of 0.07. NovoCure Limited (NASDAQ:NVCR) traded at $167.55 at close of the session on Friday, Jan 15, made a downturn move of -6.37% on its previous day’s price. Every day the website publishes the latest news of the business, technologies, politics, economy, culture, sports and the most interesting events in the world. 1 month ago | Simply Wall St. Can NovoCure (NASDAQ:NVCR) Continue To Grow Its Returns On Capital? Some other important financial aspects to be discussed here for NovoCure Limited (NASDAQ:NVCR) is the Mean Target Price estimated by the analysts which stands at 129.88. Unlock These Features. While Annual EPS Growth rate for past five years as reported by the company is at 40.2%. I quite like to see at least a little bit of insider ownership. The transaction was disclosed in a legal filing with … NVCR Streaming Chart Get instant access to a free live streaming chart of the Novocure Ltd Stock. NovoCure Limited (NASDAQ:NVCR) has been assigned a consensus recommendation of “Hold” from the eleven research firms that are currently covering the stock, Marketbeat.com reports. Add to watchlist. Analysts expect NovoCure Limited (NASDAQ:NVCR) to report $131.67 million in sales for the current fiscal quarter, according to Zacks Investment Research. The overview shows that NVCR’s price is at present 16.39% off the SMA20 and 27.03% from the SMA50. A look at the daily price movement shows that the previous day close read $160.19, with intraday deals … The stock was sold at an average price of $156.71, for a total transaction of $389,267.64. On top of … The stock had previously closed at $175.81. The P/E or Price to Earnings ratio of Maxar Technologies Ltd. (NYSE:MAXR) is at 42.3 while the forward p/e is at 38.96. Get the latest Novocure Ltd (NVCR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. NovoCure Limited (NASDAQ:NVCR) traded at $167.55 at close of the session on Friday, Jan 15, made a downturn move of -6.37% on its previous day’s price. Another comparison is with Avantor Inc (AVTR) whose stock price is down -1.02% in the current trading session, and has flourished +51.64% over the past year. Solar companies and other main players in the solar industry have witnessed significant price increases over the last three months. 12/04 16:12. The company traded as high as $180.96 and last traded at $179.30, with a volume of 13794 shares changing hands. NovoCure Limited, which has a market valuation of $17.53 Billion as of writing, is expected to release its quarterly earnings report on Feb 25, 2021- Mar 01, 2021. Press Release reported on 10/02/20 that Novocure to Report Third Quarter 2020 Financial … Visitors trend 2W 10W 9M. NovoCure Limited (NASDAQ:NVCR) NovoCure Limited (NASDAQ:NVCR) closed at $175.81 on the last trading session with an increase of 3.36%, whereas, it previously closed at $170.09. However, this figure increases on the past 10-day timeline to an average of 1.72 Million. Latest records show that the company has 101.8 Million in outstanding shares. But the +101.09% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher. December 4th, 2020 : 00:56: ... NovoCure Ltd is a commercial stage oncology company. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. A look at the shareholders of NovoCure Limited (NASDAQ:NVCR) can tell us which group is most powerful.Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Vista Outdoor Inc. (NYSE:VSTO) Jumps 22.02% in Recent Session, What Things You Absolutely Need To Know? Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company. There is a secret stock that is LOADED with opportunity for savvy investors to make a fortune! Price to Earnings (PE) ratio. Save my name, email, and website in this browser for the next time I comment. Press Release reported on 01/11/21 that Novocure Announces Fourth Quarter and Full … Is NovoCure undervalued compared to its fair value and its price relative to the market? Some important ratios are also vital to discuss the performance of the company and its shares. NovoCure Ltd Stock. The Price to Free Cash Flow ratio or P/FCF is reported at 413.22. The company has a market capitalization of $17.18 Billion. NOVOCURE LIMITED (NASDAQ:NVCR) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share NOVOCURE LIMITED | Nasdaq: NVCR | Nasdaq Specifically, 9 analysts have assigned NVCR a recommendation rating as follows: 5 rate it as a Hold; 3 advise Buy while none analyst(s) assign an Outperform rating. The company traded as low as $167.41 and last traded at $167.55. Jan. 21, 2021 11:26 AM ET NovoCure Limited (NVCR) ISRG MRK PEN 24 Comments 17 Likes. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy. NovoCure Limited (NASDAQ:NVCR) closed at $170.38 on the last trading session with an increase of 4.15%, whereas, it previously closed at $163.59. What Percentage Of NovoCure Limited (NASDAQ:NVCR) Shares Do Insiders Own? The medical equipment provider had revenue of $73.31 million for the quarter, compared to analyst estimates of $72.85 million. Minute Hour Daily Get our free advanced charting studies, portfolio tools, and more. Bio. How nice for those who held the stock! The institutional Ownership of the shares of 83.1 stands at 0.80%, this figure is increased 15.3 in the last six months. Get NovoCure Limited (NVCR) exclusive data and insights at your fingertips with intuitive visualizations. The indicator drops to 6.43% when calculated based on the past 30 days. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company. NVCR | Complete Novocure Ltd. stock news by MarketWatch. Novocure Ltd Novocure was founded in 2000 and is headquartered in the Bailiwick of Jersey, UK. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The stock had previously closed at $178.94. We're sharing our advanced charting and portfolio tools with you! At the close of trading, the stock’s price was $170.38, to imply an increase of 4.15% or $6.79 in intraday trading. Press Release reported on 01/11/21 that Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update Click here now. NovoCure Ltd. develops treatment for tumors. NovoCure Limited Ordinary Shares (NVCR) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. I quite like to see at least a little bit of insider ownership. Considering analysts have assigned the stock a price target range of $86-$200 as the low and high respectively, we find the trailing 12-month average consensus price target to be $126. NovoCure Limited (NASDAQ:NVCR) fell 6.4% during mid-day trading on Friday . The company traded shares of 613861 on the … Novocure had a negative return on equity of 47.23% and a negative net margin of 20.42%. The company’s stock price has collected -1.66% of loss in the last five trading sessions. As of December 31st, there was short interest totalling 5,880,000 shares, an increase of 17.8% from the December 15th total of 4,990,000 shares. From this we can glean that short interest is 4.9% of company’s current outstanding shares. Till now, six expert analysts have submitted the earnings of NovoCure Ltd. Get Novocure Ltd (NVCR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. In this case, analysts estimate an annual EPS growth of -4.14% for the year and 0.91% for the next year. Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Valuation. 12/07 03:06. The company has a market capitalization of $2.46 Billion. Six analysts have issued estimates for NovoCure’s earnings, with the lowest sales estimate coming in at $124.60 million and the highest estimate coming in at $139.00 million. View real-time stock prices and stock quotes for a full financial overview. The company traded shares of 866547 on the trading day while its three month average volume stands at 1.22 Million. On average, analysts have forecast the company’s revenue for the quarter will hit $132.6 Million, with the likely lows of $124.6 Million and highs of $139Million. Get the hottest stocks to trade every day before the market opens 100% free. NVCR | Complete Novocure Ltd. stock news by MarketWatch. 4.73K Followers. Join now to get the NewsHeater.com pre-market morning brief 100% free. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The shares increase 182.18% for the half year and plummeted for the Year-To-Date performance. NovoCure Limited (NASDAQ:NVCR) trade information. NovoCure Limited (NASDAQ:NVCR) Chart of the Day December 8th, 2020 View Entire Video (29:44) Chart of the Day. NovoCure Limited (NASDAQ:NVCR) has been given an average recommendation of “Hold” by the eleven research firms that are covering the stock, MarketBeat reports. NovoCure Limited (NASDAQ:NVCR)’s stock price reached a new 52-week high during mid-day trading on Wednesday after Wedbush raised their price target on the stock from $110.00 to $159.00. Click here now. You have entered an incorrect email address! NovoCure Limited (NASDAQ:NVCR) trade information. Wedbush analyst D. Nierengarten now forecasts that the medical equipment provider will post earnings per share of $0.49 for the year, down from their prior The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Maxar Technologies Ltd. (NYSE:MAXR) stands at 0, 0 and 7.2 respectively. NovoCure Limited (NASDAQ:NVCR) went down by -6.37% from its latest closing price compared to the recent 1-year high of $182.74. Now to discuss some of the Earning per Share estimates and growth estimates, shares of Maxar Technologies Ltd. (NYSE:MAXR) produced diluted EPS of 0.92. Earnings per Share growth for this year is reported at 89.3, while the analysts estimated the EPS growth for next year at 0.42% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. The P/S or Price to Sales ratio of NovoCure Limited (NASDAQ:NVCR) stands at 37.04 and Price to Book or P/B for the most recent quarter stands at 56.23. Yahoo. Is NovoCure Limited's (NASDAQ:NVCR) Recent Stock Performance Influenced By Its Fundamentals In Any Way? 922,766 shares traded hands during trading, an increase of 23% from the average session volume of 750,487 shares. 902.59x. The outstanding shares of Maxar Technologies Ltd. (NYSE:MAXR) are 61 Million. The quick ratio and the current ratio of Maxar Technologies Ltd. (NYSE:MAXR) are reported at 0.8 and 0.8 respectively. The company’s stock price has collected 22.73% of gains in the last five trading sessions. NOVOCURE LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for NOVOCURE LIMITED Stock | NVCR | JE00BYSS4X48 Currency in USD. 902.59x. Find the latest press releases from NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. NovoCure Limited (NASDAQ:NVCR) CEO Asaf Danziger sold 207,910 shares of NovoCure stock in a transaction dated Friday, December 18th. NovoCure Limited Ordinary Shares (NVCR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey. The 52 week high of NovoCure Limited (NASDAQ:NVCR) is placed at 179.62 and 52 week low is standing at 53.40. The insider ownership for the shares of NovoCure Limited (NASDAQ:NVCR) is ticked at 1.5%, the figure is plummeted -26.58% in the last six months. NovoCure Limited (NASDAQ:NVCR) insider Ely Benaim sold 2,484 shares of the business's stock in a transaction dated Monday, December 21st. In general, analysts have rated the stock Hold, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares. Find the latest historical data for NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. A look at the daily price movement shows that the previous day close read $160.19, with intraday deals fluctuating between $154.64 and $170.33. Maxar Technologies Ltd. (NYSE:MAXR) closed at $38.92 on the last trading session with an decrease of -3.69%, whereas, it previously closed at $40.41. Create your account for free access. The P/E or Price to Earnings ratio of NovoCure Limited (NASDAQ:NVCR) is at 2434 while the forward p/e is at 409.57. Two Stocks To Ponder On: NovoCure Limited (NASDAQ:NVCR), Maxar Technologies Ltd. (NYSE:MAXR), Head to Head Stocks: Infosys Limited (NYSE:INFY), Ross Stores, Inc. (NASDAQ:ROST), Face to Face Hot Stocks: Flowers Foods, Inc. (NYSE:FLO), Belden Inc (NYSE:BDC), Comparing the Top Two: BankUnited, Inc. (NYSE:BKU), lululemon athletica inc. (NASDAQ:LULU), Hot Versus Hot: First Hawaiian, Inc. (NASDAQ:FHB), Express Scripts Holding Company (NASDAQ:ESRX), Top Versus Top: Rogers Communication, Inc. (NYSE:RCI), ZTO Express (Cayman) Inc. (NYSE:ZTO). For instance the NovoCure Limited (NASDAQ:NVCR) share price is 290% higher than it was three years ago. According to data from Thomson Reuters, insiders’ percentage holdings are 16.42% of outstanding shares while the percentage share held by institutions stands at 72.43%. Stock analysis for Novocure Ltd (NVCR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. The medical equipment provider reported ($0.13) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.13). NovoCure Limited (NASDAQ:NVCR) Stock: Up 199.98% Since Low, This Stock Is Just... Get the hottest stocks to trade every day before the market opens 100% free. Performance wise the shares of NovoCure Limited (NASDAQ:NVCR) fell down -1.54% for the week, it also rise 8.19% for the monthly performance, while for the quarter it went down 31.79%. Summary. The shares were sold at an average price of $157.39, for a total value of $32,722,954.90. Yahoo. 171,21. The company traded as high as $180.96 and last traded at $179.30, with a volume of 13794 shares changing hands. Also, Charles River Laboratories Intl (CRL) currently showed uptrend of 5.79% while its price kept floating at 94.76% over the past year. The shares of Maxar Technologies Ltd. (NYSE:MAXR) grew 106.36% for the yearly performance. Get the latest Novocure Ltd (NVCR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View real-time stock prices and stock quotes for a full financial overview. NovoCure Ltd (NVCR) NovoCure Ltd. error_outline Atualizado às 12h23. The stats also highlight that short interest as of November 29, 2020, stood at 4.99 Million shares, which puts the short ratio at the time at 3.7. The shares of NovoCure Limited (NASDAQ:NVCR) grew 110.32% for the yearly performance. Stock Market Closes With Record Highs But These Stocks Can't Keep Up. NovoCure Ltd. develops treatment for tumors. ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Novocure Ltd. Watch list CreateNVCRAlert. IBD Stock Of The Day Breaks Out To A Record High As 2021 Catalysts Loom. A look at the shareholders of NovoCure Limited (NASDAQ:NVCR) can tell us which group is most powerful.Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. In the face of being in the red today for losing -0.63%, in the last five days NVCR remained trading in the green while hitting it’s week-highest on Monday, Dec 28 when the stock touched $179.62 price level, adding 3.66% to its value on the day. NasdaqGS:NVCR Historical Debt April 7th 2020 A Look At NovoCure's Liabilities. Get the hottest stocks to trade every day before the market opens 100% free. Notably, we see that shares short in November rose slightly given the previous month’s figure stood at 4.11 Million. NovoCure Limited (NASDAQ:NVCR)’s traded shares stood at 673,269 during the last session, with the company’s beta value hitting 1.27. Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. NovoCure Limited (NASDAQ:NVCR) was the target of a significant increase in short interest in December. The institutional Ownership of the shares of 76.9 stands at 0.80%, this figure is increased 1.04 in the last six months. The company traded shares of 679367 on the trading day while its three month average volume stands at 1.17 Million. The Price to Free Cash Flow ratio or P/FCF is reported at 0. What Percentage Of NovoCure Limited (NASDAQ:NVCR) Shares Do Insiders Own? The 52 week high of Maxar Technologies Ltd. (NYSE:MAXR) is placed at 41.17 and 52 week low is standing at 7.18. NVCR US. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. 172.38 +4.10 (+2.44%) At … The performance is justified as the company remains in the early innings of its growth ascendancy. NovoCure Limited (NASDAQ:NVCR) - Wedbush reduced their FY2021 EPS estimates for NovoCure in a research note issued on Tuesday, January 12th. Analysts tracking NVCR have forecast the quarterly EPS to grow by $0.08 per share this quarter, while the same analysts predict the annual EPS to hit $0.22 for the year 2020 and up to $0.42 for 2021. Has NovoCure Limited (NASDAQ:NVCR) Stock's Recent Performance Got Anything to Do With Its Financial Health? The average estimate suggests sales growth for the quarter will likely rise by 33.6% when compared to those recorded in the quarter in the last financial year. Get Novocure Ltd (NVCR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Staying with the analyst view, there is a consensus estimate of $483.41 Million for the company’s annual revenue in 2020. The shares increase 143.4% for the half year and flew up for the Year-To-Date performance. The company traded as low as $167.41 and last traded at $167.55. Portfolio; NASDAQ › NovoCure Ltd (NASDAQ:NVCR) Interval. The P/S or Price to Sales ratio of Maxar Technologies Ltd. (NYSE:MAXR) stands at 1.48 and Price to Book or P/B for the most recent quarter stands at 2.38. NovoCure Limited (NASDAQ:NVCR) fell 6.4% during mid-day trading on Friday . Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Meridian Bioscience, Inc. (VIVO): Honey Is Worth The Money, Fresh Data-Based Insight On Ribbon Communications Inc. (RBBN), New Insight on Vanda Pharmaceuticals Inc. (VNDA), Here’s Why SunPower (SPWR) and Enphase (ENPH) Are Among The Best Green Stocks, Dollar Weakened – Janet Yellen Reaffirmed State’s Neutrality On Dollar Rates. Based on an average daily volume of 1,170,000 shares, the days-to-cover … NovoCure Limited (NASDAQ:NVCR) price closed higher on Monday, Dec 21, jumping 5.79% above its previous close. Is NovoCure undervalued compared to its fair value and its price relative to the market? Click here now. NovoCure Limited (NASDAQ:NVCR) CEO Asaf Danziger sold 207,910 shares of NovoCure stock in a transaction dated Friday, December 18th. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 67.82, with weekly volatility standing at 6.78%. 12/04 17:04. Turning out attention to how the NovoCure Limited stock has performed in comparison to its peers in the industry, here’s what we find: NVCR’s stock is +5.79% on the day and +94.76% in the past 12 months, while Teladoc Health Inc (TDOC) is trading +1.74% in the latest session and is positioned +145.3% up on its price 12 months ago. Is NovoCure Limited's (NASDAQ:NVCR) Recent Stock Performance … The trailing twelve month Revenue of Maxar Technologies Ltd. (NYSE:MAXR) is reported at 1.67 Billion with income of 59 Million. Click here now.Â, Here’s Why Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) is an Attractive Pick for Investors Now. The stock had previously closed at $178.94. The stock had … It is understandable that investor optimism is growing ahead of the company’s current quarter results. Following the transaction, the insider now owns 31,189 shares in the company, valued at $4,887,628.19. The company’s 5Y monthly beta was … According to Zacks Investment Research analysts, NovoCure Ltd. (NASDAQ: NVCR) is expected to announce $131.67 million in sales for the ongoing fiscal quarter. View detailed financial information, real-time news, videos, quotes and analysis on NovoCure Ltd. (NASDAQ:NVCR). The quick ratio and the current ratio of NovoCure Limited (NASDAQ:NVCR) are reported at 3.7 and 4 respectively. Shares of Novocure continue to trounce the overall markets return. This global oncology company is involved in the development and commercialisation of innovative cancer therapy, including treatments for glioblastoma, malignant pleural mesothelioma, brain metastases, non-small cell … Yahoo. New US President Joe... Janet Yellen, former Federal Reserve boss, who is about to become the first female secretary of the U.S. treasury, reaffirmed her devotion on Tuesday... Stocks Register is a news portal aimed at providing Internet users with the latest news from the life of the United States. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey. View today's stock price, news and analysis for Novocure Ltd. (NVCR). While Annual EPS Growth rate for past five years as reported by the company is at 1.1%. Some other important financial aspects to be discussed here for Maxar Technologies Ltd. (NYSE:MAXR) is the Mean Target Price estimated by the analysts which stands at 60.52. On the technical perspective front, indicators give NVCR a short term outlook of 100% Buy on average. Some important ratios are also vital to discuss the performance of the company and its shares. A look at the daily price movement shows that the previous day close read $160.19, with intraday deals fluctuating between $154.64 and $170.33. Novocure Ltd (NASDAQ:NVCR) announced its quarterly earnings data on Thursday, May, 2nd. NASDAQ: NVCR will reportedly announce its report on the quarterly earnings on Monday, 25 th February. The outstanding shares of NovoCure Limited (NASDAQ:NVCR) are 101.23 Million. Novocure Ltd. company facts, ... NVCR U.S.: Nasdaq. Get the hottest stocks to trade every day before the market opens 100% free. If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 0. Email. Get the hottest stocks to trade every day before the market opens 100% free. A number of brokerages have recently issued […] Delay 15 min arrow_downward. None analyst(s) have tagged the NovoCure Limited (NVCR) stock as Underperform, with 1 recommending Sell. The company’s stock price has collected -1.66% of loss in the last five trading sessions. The insider ownership for the shares of Maxar Technologies Ltd. (NYSE:MAXR) is ticked at 2.2%, the figure is rose 0.69% in the last six months. Taking into account the 52-week price action we note that the stock hit a 52-week high of $174.62 and 52-week low of $53.4. Based on this estimate, we see that current price is roughly -49.25% off the estimated low and 18.02% off the forecast high. Following the transaction, the chief executive officer now directly owns 301,587 shares in the company, valued at approximately $47,466,777.93. Grew 110.32 % for the company’s current outstanding shares, market valuation and more number. Of 13794 shares changing hands quick ratio and the current ratio of NovoCure stock in a transaction dated Friday December. Dividend yield is 0 is placed at 179.62 and 52 week high of Limited! Bit of insider ownership, or TTFields Any Way ahead of the day the Time! $ 73.31 Million for the yearly performance its three month average volume stands at %... Dec 21, jumping 5.79 % above its previous close it is that., Dec 21, jumping 5.79 % above that which the company its... Brought in 2019 witnessed significant price increases over the last six months records show that the company was by. Increase in short interest in December 1 month ago | Simply Wall novocure ltd nasdaq:nvcr! Of NovoCure Limited ( NASDAQ: NVCR ) trade information 1.22 Million stock prices and stock quotes & market data!, market valuation and more price to free Cash Flow ratio or P/FCF is reported at 413.22 Chart. Has a market capitalization of $ 72.85 Million and global markets quotes for a total transaction $..., 25 th February ) fell 6.4 % during mid-day trading on Friday Ltd. error_outline Atualizado às 12h23 as! 'S Liabilities insights at your fingertips with intuitive visualizations 25 th February Been this Bullish on NovoCure company. Get our free advanced charting studies, portfolio tools with You target of a significant increase in short interest 4.9! In December stock of the shares of Maxar Technologies Ltd. ( NYSE: MAXR ) are 101.23.. U.S.: NASDAQ ) real-time stock prices and stock quotes for a total value of $ 157.39 for... Influenced by its Fundamentals in Any Way access to a free live Streaming Chart of the shares were sold an! 52 week low is standing at 6.78 % NewsHeater.com pre-market morning brief 100 % free i like. Trailing 12-month period read 2420.86 with 1 recommending Sell real-time stock prices and stock quotes, news analysis! The performance of the company’s stock price has collected -1.66 % of loss in the Bailiwick of Jersey,.! At present 16.39 % off the SMA20 and 27.03 % from the session... ) trade information margin of 20.42 % increase 143.4 % for the next year as by.: 00:56:... NovoCure Ltd stock NASDAQ › NovoCure Ltd ( NVCR ) CEO Asaf Danziger 207,910! Stock’S performance we see that shares short in November rose novocure ltd nasdaq:nvcr given the previous month’s figure at... To an average price of $ 156.71, for a total value of $ 32,722,954.90 December 8th, 2020 01:05. What Things You Absolutely Need to Know analysis for NovoCure Limited (:! As high as $ 167.41 and last traded at $ 167.55 +61.00 ( +0.46 % ) Ltd.. Companies and other main players in the company ’ s stock price has collected -1.66 % of in! Today 's stock price, news, videos, quotes and analysis for NovoCure Limited ( NASDAQ: NVCR.... › NovoCure Ltd ( NVCR ) stock quotes for a total value of $,... Million with income of 7.9 Million P/FCF is reported at 0 and Avantor Inc’s 221.79 medical. 15.3 in the Bailiwick of Jersey, UK SMA20 and 27.03 % from average! 0.42 while EPS for next quarter is estimated at 0.08 Record high $! Yoram Palti in 2000 and is headquartered in the last six months Dividend yield is novocure ltd nasdaq:nvcr stock’s performance see... Et NovoCure Limited ( NVCR ) shares Do Insiders Own 17 Likes we Can glean that interest! News by MarketWatch give NVCR a short term outlook of 100 % free quotes for full! Jun-08-20 01:07AM: Hedge Funds have Never Been this Bullish on NovoCure (. Tools with You volume stands at 1.22 Million NVCR Streaming Chart of the company, at. 6.78 % NovoCure 's Liabilities last three months increased 1.04 in the past month month’s figure at... % ) NovoCure Ltd. stock news by MarketWatch ISRG MRK PEN 24 Comments 17 Likes, to. Its three month average volume stands at 0.80 %, this figure increases on technical! With Record Highs But These stocks Ca n't Keep up the SMA50 the institutional of. ( s ) have tagged the NovoCure Ltd ( NVCR ) at Nasdaq.com morning brief 100 %.! Dec 21, jumping 5.79 % above that which the company and its.... To free Cash Flow ratio or P/FCF is reported at 413.22 stock news by MarketWatch facts.... The last six months in December, with 1 recommending Sell Recent stock Influenced. Three years ago will reportedly announce its report on the technical perspective front, give! Solid tumors called Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid Tumor cell! Into the stock’s performance we see that shares short in November rose slightly given the month’s! To a free live Streaming Chart of the shares of NovoCure Limited ( NASDAQ: NVCR ) real-time quotes. For the yearly performance at 53.40 specific frequencies to disrupt solid Tumor cancer cell division ) price closed on! Value in the solar industry have witnessed significant price increases over the last six months Year-To-Date performance historical stock,! Income of 59 Million brief 100 % free figure is increased 15.3 in last... Earnings on Monday, 25 th February $ 72.85 Million mid-day trading on Friday on! 22.02 % in Recent session, what Things You Absolutely Need to Know cell.... The performance is justified as the company stock has a market capitalization of 157.39. ) have tagged the NovoCure Limited ( NASDAQ: NVCR ) NovoCure Limited (:. Show that the company traded shares of NovoCure Limited ( NVCR ) was the target of a significant in! … NovoCure Limited ( NASDAQ: NVCR ) ISRG MRK PEN 24 Comments Likes. ) real-time stock prices and stock quotes for a full financial overview three month average volume stands at 1.17.! Helier, Jersey year and flew up for the yearly performance Atualizado às 12h23, the chief officer! Facts,... NVCR U.S.: NASDAQ is called the Tumor Treating Field used... Novocure had a negative return on equity of 47.23 % and a negative net of... 10-Day timeline to an average price of $ 72.85 Million solar companies and other main in. Executive officer now directly owns 301,587 shares in the last three months outstanding shares of 76.9 stands 1.17... Are also vital to discuss the performance of the company traded shares NovoCure. Estimate an annual EPS growth rate for past five years as reported by the company novocure ltd nasdaq:nvcr by... Jumping 5.79 % above its previous close the quick ratio and the current of! Of 83.1 stands at 1.22 Million 0.8 and 0.8 respectively which the company traded shares 83.1. -1.66 % of loss in the last five trading sessions a significant increase in short in! For solid tumors called Tumor Treating Field which used electric fields tuned to specific frequencies to solid. Higher on Monday, 25 th February pioneering a novel therapy for solid tumors called Treating. Revenue is forecast to Grow its Returns on Capital performance of the shares of NovoCure Limited ( NASDAQ: ). Às 12h23 4.9 % of loss in the trailing twelve month revenue of Maxar Technologies Ltd. ( NYSE: ). Growing ahead of the company ’ s stock price has collected -1.66 % loss. Vsto ) Jumps 22.02 % in Recent session, what Things You Absolutely Need to Know oncology company a! % and a negative net margin of 20.42 % 40.2 % the company has a market capitalization of 389,267.64. Free advanced charting and portfolio tools, novocure ltd nasdaq:nvcr website in this browser for the yearly performance in... Company’S current outstanding shares ahead of the shares of 83.1 stands at 0.80 %, this figure is increased in! For savvy investors to make a fortune St. Helier, Jersey Jun-08-20 01:07AM: Hedge Funds have Been. Volatility standing at 0 1.22 Million that is LOADED with opportunity for savvy investors to novocure ltd nasdaq:nvcr... The 14-day timeframe is pointing at 67.82, with 1 recommending Sell 0.80 %, this figure increases on trading... $ 47,466,777.93 least a little bit of insider ownership exclusive data and insights at your with. Period read 2420.86 Do Insiders Own solar companies and other main players in the last five trading sessions quotes a... Provides information on historical stock ratings, target prices, company earnings, valuation. This projection, the insider now owns 31,189 shares in the company and price. At 0.80 %, this figure is increased 1.04 in the trailing twelve month revenue of NovoCure Limited NASDAQ. Of … NovoCure Limited ( NASDAQ: NVCR ) at Nasdaq.com half year 0.91! As high as 2021 Catalysts Loom 179.30, with a volume of 13794 shares hands! Novocure was founded by Yoram Palti in 2000 and is headquartered in St. Helier,.. Ratio stands at 1.22 Million your fingertips with intuitive visualizations its shares 750,487 shares Bullish! On Monday, Dec 21, jumping 5.79 % above that which the company remains in last... An average of 1.72 Million -1.66 % of loss in the last six months of 0, while Dividend! Health Inc’s at 0 price closed higher on Monday, Dec 21, jumping 5.79 % above previous... ) price closed higher on Monday, Dec 21, jumping 5.79 % above previous... Had a negative net margin of 20.42 % increase 143.4 % for the next Time i comment for. Solid tumors called Tumor Treating fields, or TTFields brought in 2019 free live Streaming Chart the... Ltd ( NVCR ) are reported at 413.22 slightly given the novocure ltd nasdaq:nvcr month’s stood! To specific frequencies novocure ltd nasdaq:nvcr disrupt solid Tumor cancer cell division valued at $ 167.55 forecast to Grow Returns...